Current status of cardiac regenerative medicine; An update on point of view to cell therapy application
Open Access
- 24 November 2020
- journal article
- review article
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 12 (4), 256-268
- https://doi.org/10.34172/jcvtr.2020.44
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death globally. Because of the economic and social burden of acute myocardial infarction and its chronic consequences in surviving patients, understanding the pathophysiology of myocardial infarction injury is a major priority for cardiovascular research. MI is defined as cardiomyocytes death caused by an ischemic that resulted from the apoptosis, necrosis, necroptosis, and autophagy. The phases of normal repair following MI including inflammatory, proliferation, and maturation. Normal repair is slow and inefficient generally so that other treatments are required. Because of difficulties, outcomes, and backwashes of traditional therapies including coronary artery bypass grafting, balloon angioplasty, heart transplantation, and artificial heart operations, the novel strategy in the treatment of MI, cell therapy, was newly emerged. In cell therapy, a new population of cells has created that substitute with damaged cells. Different types of stem cell and progenitor cells have been shown to improve cardiac function through various mechanisms, including the formation of new myocytes, endothelial cells, and vascular smooth muscle cells. Bone marrow- and/or adipose tissue-derived mesenchymal stem cells, embryonic stem cells, autologous skeletal myoblasts, induced pluripotent stem cells, endothelial progenitor cells, cardiac progenitor cells and cardiac pericytes considered as a source for cell therapy. In this study, we focused on the point of view of the cell sources.Keywords
This publication has 96 references indexed in Scilit:
- Human Pericytes for Ischemic Heart RepairThe International Journal of Cell Cloning, 2013
- Matricellular Proteins in Cardiac Adaptation and DiseasePhysiological Reviews, 2012
- Cardiomyocyte death: mechanisms and translational implicationsCell Death & Disease, 2011
- New roles for mitochondria in cell death in the reperfused myocardiumCardiovascular Research, 2011
- Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132Circulation Research, 2011
- Human Placental Pericytes Poorly Stimulate and Actively Regulate Allogeneic CD4 T Cell ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Regenerative Therapies Using Cell Sheet-Based Tissue Engineering for Cardiac DiseaseCardiology Research and Practice, 2011
- Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmAAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The immune system and cardiac repairPharmacological Research, 2008
- Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell deathNature, 2005